作者：
Christopher R,Flowers [1]
;
Luciano J,Costa [2]
;
Marcelo C,Pasquini [3]
;
Jennifer,Le-Rademacher [3]
;
Michael,Lill [4]
;
Tsiporah B,Shore [5]
;
William,Vaughan [6]
;
Michael,Craig [7]
;
Cesar O,Freytes [8]
;
Thomas C,Shea [9]
;
Mitchell E,Horwitz [10]
;
Joseph W,Fay [11]
;
Shin,Mineishi [12]
;
Damiano,Rondelli [13]
;
James,Mason [14]
;
Ira,Braunschweig [15]
;
Weiyun,Ai [16]
;
Rosa F,Yeh [17]
;
Tulio E,Rodriguez [18]
;
Ian,Flinn [19]
;
Terrance,Comeau [20]
;
Andrew M,Yeager [21]
;
Michael A,Pulsipher [22]
;
Isabelle,Bence-Bruckler [23]
;
Pierre,Laneuville [24]
;
Philip,Bierman [25]
;
Andy I,Chen [26]
;
Kazunobu,Kato [27]
;
Yanlin,Wang [27]
;
Cong,Xu [27]
;
Angela J,Smith [27]
;
Edmund K,Waller [28]
作者单位：
Department of Hematology and Medical Oncology, Winship Cancer Institute, Division of BMT, Emory University, Atlanta, Georgia.
[1]
Medical University of South Carolina, Charleston, South Carolina.
[2]
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
[3]
Cedars-Sinai Medical Center, Los Angeles, California.
[4]
Weill Cornell Medical Center Hematology/Oncology, The New York Hospital, New York, New York.
[5]
Bone Marrow Transplantation Program, University of Alabaman at Birmingham, Birmingham, Alabama.
[6]
West Virginia University, Health Science Center, Morgantown, West Virginia.
[7]
South Texas Veterans Health Care System, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
[8]
Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.
[9]
Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
[10]
Baylor University Medical Center, Dallas, Texas.
[11]
Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan.
[12]
Department of Medicine, Section of Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
[13]
Scripps Clinic, La Jolla, California.
[14]
Department of Oncology, Montefiore Medical Center, Bronx, New York.
[15]
Medicine, University of California, San Francisco, San Francisco, California.
[16]
Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, Washington.
[17]
Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois.
[18]
Sarah Cannon Research Institute, Nashville, Tennessee.
[19]
New Brunswick Stem Cell Transplant Program, St. John, New Brunswick, Canada.
[20]
Blood and Marrow Transplantation Program, The University of Arizona Cancer Center, Tucson, Arizona.
[21]
Division of Hematology, Oncology, and Blood and Marrow Transplant, Children's Hospital Los Angeles, Keck School of Medicine and University of Southern California, Los Angeles, California.
[22]
The University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada.
[23]
Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
[24]
Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
[25]
Center for Hematologic Malignancies, Oregon Health & Science University, Portland, Oregon.
[26]
Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
[27]
Department of Hematology and Medical Oncology, Winship Cancer Institute, Division of BMT, Emory University, Atlanta, Georgia. Electronic address: ewaller@emory.edu.
[28]
DOI
10.1016/j.bbmt.2016.03.018
PMID
27040394
发布时间
2024-03-25
换一批
换一批
